SCHEMBL20150299

SCHEMBL20150299

Cc1ccc2c3ccc(C(F)(F)F)cc3n(-c3cc(-c4nc(C)nc(C)n4)ccc3C#N)c2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 3/20 0.37
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.33
TSHR P16473 1/20 0.33
KIF11 P52732 2/20 0.33
RAF1 P04049 1/20 0.33
BRAF P15056 1/20 0.33
MAT2A P31153 4/20 0.32
PDE10A Q9Y233 1/20 0.32
NPBWR1 P48145 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
BCAT1 P54687 1/20 0.32
XDH P47989 1/20 0.32
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20114669 0.96 PSEN1 (0.36) ARPSEN1PSEN2APH1BNCSTN
SCHEMBL20114667 0.91 KIF11 (0.42) ARPSEN1PSEN2APH1BNCSTN
SCHEMBL20150292 0.90 MAOA (0.35) ARMAT2ACYP11B1CYP11B2XDH
SCHEMBL20150320 0.89 AR (0.36) ARPSEN1PSEN2APH1BNCSTN
SCHEMBL20115000 0.87 CYP11B1 (0.37) ARPSEN1PSEN2APH1BNCSTN
SCHEMBL20114995 0.86 AR (0.36) ARPSEN1PSEN2APH1BNCSTN
SCHEMBL20150295 0.86 XDH (0.34) KIF11MAT2AXDH
SCHEMBL20150322 0.86 AR (0.36) ARPSEN1PSEN2APH1BNCSTN
SCHEMBL20114509 0.85 KDM4E (0.35) SMN1; SMN2MAT2ALMNAMAPTHTT
SCHEMBL20150331 0.84 ALDH1A1 (0.35) SMN1; SMN2TSHRMAT2ACYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 AR 3892/4885PSEN1 3522/4885PSEN2 2239/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.